The Cancer Epitope Database and Analysis Resource (CEDAR)

Zeynep Koşaloğlu(La Jolla Institute for Immunology), Nina Blazeska(La Jolla Institute for Immunology), Randi Vita(La Jolla Institute for Immunology), Hannah Carter(University of California San Diego), Morten Nielsen(National University of General San Martín), Stephen P. Schoenberger(La Jolla Institute for Immunology), Alessandro Sette(La Jolla Institute for Immunology), Bjoern Peters(La Jolla Institute for Immunology)
Nucleic Acids Research
October 17, 2022
Cited by 67Open Access
Full Text

Abstract

We established The Cancer Epitope Database and Analysis Resource (CEDAR) to catalog all epitope data in the context of cancer. The specific molecular targets of adaptive T cell and B cell immune responses are referred to as epitopes. Epitopes derived from cancer antigens are of high relevance as they are recognized by anti-cancer immune cells. Detailed knowledge of the molecular characteristic of cancer epitopes and associated metadata is relevant to understanding and planning prophylactic and therapeutic applications and accurately characterizing naturally occurring immune responses and cancer immunopathology. CEDAR provides a freely accessible, comprehensive collection of cancer epitope and receptor data curated from the literature and serves as a companion site to the Immune Epitope Database (IEDB), which is focused on infectious, autoimmune, and allergic diseases. CEDAR is freely accessible at https://cedar.iedb.org/.


Related Papers

No related papers found

Powered by citation graph analysis